1,2-Benzisoxazole, 4H-pyrido[1,2-a]pyrimidin-4-one deriv.

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 26 USDMF, 11 EU WC, 3 KDMF, 13 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

10 API Suppliers

10 API Suppliers

FINISHED DOSAGE FORMULATIONS

166 FDF Dossiers, 45 FDA Orange Book, 63 Europe, 3 Canada, 14 Australia, 7 South Africa, 34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 3MG, TABLET, EXTENDED RELEASE;ORAL - 6MG, TABLET, EXTENDED RELEASE;ORAL - 9MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 SPI Pharma, 2 Seqens, 11 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 22 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 2 Finar, 6 Gangwal Chemicals, 6 Ideal Cures Pvt Ltd, 28 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 4 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 17 Direct Compression, 15 Solubilizers, 13 Granulation, 13 Lubricants & Glidants, 13 Film Formers & Plasticizers, 12 Topical, 10 Thickeners and Stabilizers, 9 Parenteral, 7 Disintegrants & Superdisintegrants, 6 Co-Processed Excipients, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 Taste Masking, 1 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 27 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 46 Finished Drug Prices, 3 Annual Reports

MARKET PLACE

10 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 Health Canada Patents

10 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 USP, 9 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21999 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
paliperidone(UNII: 838F01T721) (paliperidone - UNII:838F01T721)	paliperidone	3mg

Inactive Ingredients

Ingredient Name	Avera McKennan Hospital	REMEDYREPACK INC.
BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
carnauba wax(R12CBM0EIZ)
CELLULOSE ACETATE(3J2P07GVB6)
ferrosoferric oxide(XM0M87F357)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
hypromelloses(3NXW29V3WO)
lactose monohydrate(EWQ57Q8I5X)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
polyethylene glycols(3WJQ0SDW1A)
povidone, unspecified(FZ989GH94E)
povidones(FZ989GH94E)
propylene glycol(6DC9Q167V3)
sodium chloride(451W47IQ8X)
stearic acid(4ELV7Z65AP)
TITANIUM DIOXIDE(15FIX9V2JP)
TRIACETIN(XHX3C3X673)

Drug Product Composition: 1,2-Benzisoxazole, 4H-pyrido[1,2-a]pyrimidin-4-one deriv.